FIGS, Inc. (NYSE: FIGS) stock is surging 14.36% in pre-market trading on Friday, following the release of its impressive third-quarter 2025 financial results and an optimistic outlook for the full year. The healthcare apparel maker significantly outperformed analyst expectations, demonstrating robust growth and improved profitability.

FIGS reported quarterly earnings of $0.05 per share, surpassing the analyst consensus estimate of $0.02 by 212.5%. This marks a substantial turnaround from the $0.01 loss per share reported in the same period last year. The company's revenue also beat expectations, coming in at $151.7 million, 6.42% above the analyst consensus estimate and representing an 8.2% year-over-year increase. Net income surged to $8.7 million, compared to a net loss of $1.7 million in the prior-year quarter.

Looking ahead, FIGS raised its full-year 2025 outlook, projecting net revenue growth of about 7.0%, up from its previous forecast of low single-digit growth. The company also increased its adjusted EBITDA margin guidance to approximately 10.3% from the previous range of 8.5%-9%. This positive outlook, combined with the strong quarterly results, has fueled investor optimism and contributed to the stock's significant pre-market surge.